Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C BORDEN

Showing results (271-280 of 327) with videos related to

Pageof 33
Sort By:
The Journal of Clinical Investigation|October 1, 1990
A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humansJ H Schiller, B Storer, D M Paulnock, et al.
Cancer Research|August 1, 1990
Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusionJ H Schiller, B Storer, P L Witt, et al.
Nature Reviews. Drug Discovery|December 1, 2007
Interferons at age 50: past, current and future impact on biomedicineErnest C Borden, Ganes C Sen, Gilles Uze, et al.
Neuro-Oncology|June 4, 2011
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastomaBaisakhi Raychaudhuri, Patricia Rayman, Joanna Ireland, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 13, 2002
Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1)Mamta Chawla-Sarkar, Douglas W Leaman, Barbara S Jacobs, et al.
Clinical Pharmacology and Therapeutics|March 7, 2007
Gene modulatory effects, pharmacokinetics, and clinical tolerance of interferon-alpha1b: a second member of the interferon-alpha familyP Masci, T Olencki, L Wood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2006
Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylationFrederic J Reu, Soo In Bae, Leonid Cherkassky, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1991
Immunological effects of levamisole in vitroJ H Schiller, M Lindstrom, P L Witt, et al.
American Journal of Clinical Oncology|October 1, 1990
Phase II trial of carboplatin in soft-tissue sarcomaD Goldstein, B Cheuvart, D L Trump, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2005
Sodium stibogluconate interacts with IL-2 in anti-Renca tumor action via a T cell-dependent mechanism in connection with induction of tumor-infiltrating macrophagesKeke Fan, Ming Zhou, Manas K Pathak, et al.
Pageof 33

Showing results (271-280 of 327) with videos related to

Sort By:
Pageof 33
The Journal of Clinical Investigation|October 1, 1990
A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humansJ H Schiller, B Storer, D M Paulnock, et al.
Cancer Research|August 1, 1990
Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusionJ H Schiller, B Storer, P L Witt, et al.
Nature Reviews. Drug Discovery|December 1, 2007
Interferons at age 50: past, current and future impact on biomedicineErnest C Borden, Ganes C Sen, Gilles Uze, et al.
Neuro-Oncology|June 4, 2011
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastomaBaisakhi Raychaudhuri, Patricia Rayman, Joanna Ireland, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 13, 2002
Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1)Mamta Chawla-Sarkar, Douglas W Leaman, Barbara S Jacobs, et al.
Clinical Pharmacology and Therapeutics|March 7, 2007
Gene modulatory effects, pharmacokinetics, and clinical tolerance of interferon-alpha1b: a second member of the interferon-alpha familyP Masci, T Olencki, L Wood, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2006
Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylationFrederic J Reu, Soo In Bae, Leonid Cherkassky, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1991
Immunological effects of levamisole in vitroJ H Schiller, M Lindstrom, P L Witt, et al.
American Journal of Clinical Oncology|October 1, 1990
Phase II trial of carboplatin in soft-tissue sarcomaD Goldstein, B Cheuvart, D L Trump, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2005
Sodium stibogluconate interacts with IL-2 in anti-Renca tumor action via a T cell-dependent mechanism in connection with induction of tumor-infiltrating macrophagesKeke Fan, Ming Zhou, Manas K Pathak, et al.
Pageof 33